PETRUKHIN KONSTANTIN has a total of 18 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2004. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ALGOMEDIX INC, FOGHORN THERAPEUTICS INC and REDDY BANDI PARTHASARADHI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 18 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Measuring microorganism processes | |
#6 | Microorganisms | |
#7 | Animal care | |
#8 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Petrukhin Konstantin | 18 |
#2 | Cioffi Christopher | 8 |
#3 | Conlon Michael | 6 |
#4 | Chen Ping | 6 |
#5 | Freeman Emily | 6 |
#6 | Johnson Graham | 6 |
#7 | Zhu Lei | 6 |
#8 | Allikmets Rando | 5 |
#9 | Dobri Nicoleta | 4 |
#10 | Sparrow Janet R | 2 |
Publication | Filing date | Title |
---|---|---|
US2016046632A1 | Octahydropyrrolopyrroles their preparation and use | |
US2016030422A1 | Rbp4 antagonists for the treatment of age-related macular degeneration and stargardt disease | |
US2015126494A1 | Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease | |
US2013189246A1 | Treatment of ophthalmic conditions with fluorenone derivatives | |
US2006105364A1 | Best's macular dystrophy gene | |
US2005262580A1 | Transgenic mouse with a targeted deletion of Elovl4 gene | |
US2006287394A1 | Composition and method for treating macular disorders |